These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Hemodynamic alterations in cirrhosis and portal hypertension. Kim MY; Baik SK; Lee SS Korean J Hepatol; 2010 Dec; 16(4):347-52. PubMed ID: 21415576 [TBL] [Abstract][Full Text] [Related]
26. Pathophysiology of portal hypertension. Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769 [TBL] [Abstract][Full Text] [Related]
27. NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Wiest R; Shah V; Sessa WC; Groszmann RJ Am J Physiol; 1999 Apr; 276(4):G1043-51. PubMed ID: 10198349 [TBL] [Abstract][Full Text] [Related]
28. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Fernandez M; Mejias M; Garcia-Pras E; Mendez R; Garcia-Pagan JC; Bosch J Hepatology; 2007 Oct; 46(4):1208-17. PubMed ID: 17654489 [TBL] [Abstract][Full Text] [Related]
29. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Wu Y; Burns RC; Sitzmann JV Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267 [TBL] [Abstract][Full Text] [Related]
30. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension. Iwakiri Y J Clin Gastroenterol; 2007; 41 Suppl 3():S288-94. PubMed ID: 17975478 [TBL] [Abstract][Full Text] [Related]
31. Augmented endogenous nitric oxide production in partial portal vein-ligated rats. Hori N; Takahashi H; Okanoue T; Sawa Y; Mori T; Takami S; Yoshimura M; Kashima K Clin Exp Pharmacol Physiol; 1995 Aug; 22(8):506-11. PubMed ID: 7586705 [TBL] [Abstract][Full Text] [Related]
32. Lack of effect of indomethacin on systemic and splanchnic haemodynamics in portal hypertensive rats. Blanchart A; Hernando N; Fernández-Muñoz D; Hernando L; López-Novoa JM Clin Sci (Lond); 1985 May; 68(5):605-7. PubMed ID: 3884241 [TBL] [Abstract][Full Text] [Related]
33. Portal hemodynamics in chronic liver disease. Nagral A; Patch D; Burroughs AK Indian J Gastroenterol; 1999; 18(2):78-83. PubMed ID: 10319539 [TBL] [Abstract][Full Text] [Related]
34. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model]. Wang CT; Kuang YL; Chen ZP Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436 [TBL] [Abstract][Full Text] [Related]
35. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. Martin PY; Ginès P; Schrier RW N Engl J Med; 1998 Aug; 339(8):533-41. PubMed ID: 9709047 [No Abstract] [Full Text] [Related]
36. [Portal hypertension and the endothelium]. Marecková Z; Horký K Cesk Fysiol; 2001 Feb; 50(1):19-24. PubMed ID: 11268558 [TBL] [Abstract][Full Text] [Related]
37. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis. Gatta A; Bolognesi M; Merkel C Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654 [TBL] [Abstract][Full Text] [Related]
38. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats. Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305 [TBL] [Abstract][Full Text] [Related]
39. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin. Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773 [TBL] [Abstract][Full Text] [Related]